| Literature DB >> 18073777 |
C D Chambers1, J E Polifka, J M Friedman.
Abstract
Although clinical trials address questions regarding drug safety for most segments of the population, pregnant women constitute one special group that is "orphaned" with respect to this issue. The lack of adequate pregnancy safety information for the vast majority of medications, combined with a need to make appropriate treatment decisions and to communicate risk information to a potentially vulnerable population, are some of the most challenging and critical women's health issues.Entities:
Mesh:
Year: 2007 PMID: 18073777 DOI: 10.1038/sj.clpt.6100448
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875